Methadone injectable

Methadone injectable

Form: Injectable Solution

Strength: 10 mg/mL, 50 mg/mL, 100 mg/mL

Reference Brands: Generics & Methadose(US)

Category: Analgesic

Methadone injectable is approved in the US and EU for severe pain management and opioid dependence therapy. In the US, brands like Dolophine and generic formulations are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality, with strict controls for abuse potential. In the EU, it is regulated by EMA, with approval requiring comprehensive dossiers including clinical data and pharmacovigilance plans. Both regions enforce rigorous prescribing guidelines and monitoring to ensure safety. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for methadone injections, ensuring adherence to European and American standards for safe, effective opioid therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more